21st International Conference on Emergency Medicine 2022

14 – 19 June

Hybrid Conference I Melbourne Convention and Exhibition Centre

21st International Conference on Emergency Medicine

14 – 19 June 2022

Hybrid Conference
Melbourne Convention and Exhibition Centre

21st International Conference on Emergency Medicine 2022

14 – 19 June

Hybrid Conference I Melbourne Convention and Exhibition Centre
PARTNER PROGRAM SPONSOR
12:30 – 1:30PM
FRIDAY 17 JUNE

LUNCH & LEARN SESSION 2

Impact of Rapid Diagnostics for Infectious Diseases in the Emergency Department

Chair: Dr Carla Lee Lau

Speakers: 

Syndromic Testing, The New Standard for Infectious Disease Diagnostics Ms Lauren Cullen & Ms Danielle Bishop

PCT Guided Patient Care in the Emergency Department: Where are we in 2022 Dr Amith Shetty 

Chair: Dr Carla Lee Lau 

Dr. Carla Lee Lau is the medical director for bioMérieux Australia and New Zealand. While at bioMérieux, Carla has held various positions including Asia Pacific regional responsibility overseeing Respiratory Solutions product portfolio which includes SARS-CoV-2 diagnostics and served as a Medical Education Liaison in the United States. She is passionate about infectious diseases and started her career in New York City working for the Department of Health and at NYU Langone Medical Center Division of Pediatric Infectious Diseases. She is a member of both Infectious Diseases Society of America and American Public Health Association.

Speaker: Ms Danielle Bishop

Danielle Bishop is the Infection Control Coordinator at both Knox Private Hospital and Bellbird Private Hospital. Her professional history includes a Post-Graduate Certificate in Management and over 9 years of nursing and administrative management experience. Previously the Nurse Unit Manager (NUM) of an acute cardiac unit, Danielle was instrumental in assisting the aged care sector during the COVID pandemic by managing a COVID positive unit at Knox Private Hospital. Danielle was then promoted to the Infection Control Manager during 2021. Following 6 months of research, Danielle was able to quantify the benefits of the BioFire Respiratory Panel from both a clinical and financial perspective. This research shaped the way Healthscope hospitals utilize the BioFire Respiratory Panel in their emergency department to help identify patients with CoVID or other respiratory pathogens. 

Speaker: Ms Lauren Cullen 

Lauren Cullen is a Registered Nurse with a Post-Graduation Certificate in Infection Control. She has extensive experience in the field of infection control since 2008 and is the current Infection Control Manager at Knox Private Hospital since 2017. Knox Private Hospital is a member of the Healthscope Hospital System. During the pandemic Lauren was instrumental in implementing the BioFire Respiratory Panel into the emergency department to help identify patients with CoVID or other respiratory pathogens. Rapid syndromic infectious disease testing in the emergency department is becoming the new standard for many hospitals in today’s world. Lauren’s passion for infection control and her cost management skills helped her hospital to justify the benefits of this new way of testing patients quickly. Not only was Lauren able to justify this new system with cost savings to her hospital but the benefit of quickly knowing the CoVID status of incoming patients was a benefit to everyone involved.

Speaker: Dr James Branley

Associate Professor James Branley is an Infectious Diseases Physician and Clinical Microbiologist at Nepean Hospital in Sydney. He is the Director of Pathology and Head of the Infectious Diseases and Microbiology department at Nepean Hospital. Dr. Branley previously headed the Division of Medicine as well as serving on the board of Nepean Blue Mountains Local Health District (NBMLHD). He is a reservist with the Air Force Specialist Reserve and holds a PhD from the University of Sydney where he researched clinical psittacosis. His main focus most recently has been on CoVID related issues.

Speaker: Dr Amith Shetty

Amith Shetty is an Emergency physician, Clinical Director in the Patient Experience and System Performance Support division at NSW Ministry of Health and currently Clinical Lead for the NSW COVID-19 Care in Community program. He is also the Medical chair of NSW Emergency Care Institute Research Committee, Senior lecturer at University of Sydney, Adjunct fellow at Centre for Health Systems and Safety Research, Macquarie University, and honorary research fellow at the Westmead Institute for Medical research.

A world leader in the field of in vitro diagnostics for more than 55 years, bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions (systems, reagents, software and services) that determine the origin of a disease to improve the health of patients. World leader in microbiology, specialized in immunoassays and leading pioneer in the syndromic molecular approach, the Company is committed worldwide on major public health issues in the field of infectious diseases, such as antimicrobial resistance, sepsis and respiratory infections.

 

Vyaire Medical Inc. is a global company, headquartered in suburban Chicago, focused exclusively on supporting breathing through every stage of life. Established from legacy brands with a 65-year history of pioneering breathing technology, the company’s portfolio of integrated solutions is designed to enable, enhance, and extend lives.

At Vyaire, our team of 4000, pledges to advance innovation and evolve what’s possible to ensure every breath is taken to its fullest. Vyaire’s products are available in more than 100 countries and are recognized, trusted, and preferred by specialists throughout the respiratory community worldwide.

Vyaire has a long and proud history with emergency care throughout Australia and beyond. As the home of legacy brands including Vital Signs, AirLife, enFlow, GreenLight, bellavista, and many more, we are your trusted partner every step in delivering emergency care.

Come speak to Vyaire to learn more about our innovative solutions in ventilation and respiratory care, and blood and fluid management in the ED.

COMPANY

Insert Bio

NAME

Face placeholder

Insert Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.